harrywalker.com wurde im letzten Monat von mehr als 10.000 Nutzern besucht
Leading Speaker's Bureau Types: Economy, Politics & Government, Global Outlook
- Business Speakers
Business, Government & The Economy
Speakers.-Learn More About Harry...
- Healthcare Economics
Healthcare Economics & Policy
Speakers-At Harry Walker Agency
- Banking Speakers
Browse our full range of-banking
and finance speakers.
- Globalization Speakers
We Can Help You Find The Perfect
Speaker For Your Event.
- Execution Speakers
Execution & Strategy Speakers-At
Harry Walker Agency.
- Business Speakers
Suchergebnisse
Suchergebnisse:
2. Okt. 2024 · Peter Orszag, Lazard CEO and former OMB Director under President Obama, joins ‘Squawk Box’ to discuss the state of the economy, impact of the port strike and the Middle East conflict, the Fed...
25. Sept. 2024 · On September 23, Business Insider published an article featuring commentary from Lazard CEO Peter Orszag on the benefits of workplace flexibility, noting that Lazard has one of the most flexible work-from home policies in the financial sector.
19. Sept. 2024 · Speaking on The David Rubenstein Show on Bloomberg, Lazard boss Peter Orszag was asked why junior bankers work 80-hour weeks. He replied that people are often willing to do work they feel gave...
7. Okt. 2024 · Trump has promised to increase tariffs on imports from China by 60 percentage points and on all other imports by 10 to 20 percentage points. His insistence that this would not make American ...
23. Sept. 2024 · Work-from-home is working for one top Wall Street firm. Peter Orszag, the CEO of Lazard says that the financial services firm has one of the most flexible work-from-home policies in the...
- Henry Blodget
2. Okt. 2024 · Peter Orszag, Lazard CEO and former OMB Director under President Obama, joins 'Squawk Box' to discuss the state of the economy, impact of the port strike and the Middle East conflict, the Fed's...
- 6 Min.
- CNBC
25. Sept. 2024 · By Peter Orszag , David Gluckman , Michael Kingston and Dale Raine. Global biopharmaceutical executives and investors face a challenging environment. Decision-makers are uncertain about the ...